Good Enough? Terlipressin, Hepatorenal Syndrome, and the Usage of RRT
Kidney360
.
2023 Aug 1;4(8):1011-1013.
doi: 10.34067/KID.0000000000000217.
Author
Justin M Belcher
1
2
Affiliations
1
Department of Internal Medicine, Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut.
2
VA Connecticut Healthcare System, West Haven, Connecticut.
PMID:
37651662
PMCID:
PMC10484352
DOI:
10.34067/KID.0000000000000217
No abstract available
Publication types
Editorial
Comment
MeSH terms
Hepatorenal Syndrome* / drug therapy
Humans
Terlipressin / therapeutic use
Substances
Terlipressin
Grants and funding
UL1 TR001863/TR/NCATS NIH HHS/United States